Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
Therapies that inhibit CETP (cholesteryl ester transfer protein) have failed to demonstrate a reduction in risk for coronary heart disease (CHD). Human DNA sequence variants that truncate the
Furkejuvvon:
Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Revisão |
Giella: | eaŋgalasgiella |
Almmustuhtton: |
2017
|
Liŋkkat: | https://doi.org/10.1161/circresaha.117.311145 https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.117.311145 |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|